|
Re: Nasdaq listing -- Awesome News!!
|
10
|
Resverlogix Corp.
|
Jul 31, 2018 07:58PM
|
|
Re: If BP buys Apabetalone,...
|
10
|
Resverlogix Corp.
|
Nov 06, 2019 12:42PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
10
|
Resverlogix Corp.
|
Sep 14, 2018 11:19PM
|
|
Re: My guess is a second BTD is coming
|
10
|
Resverlogix Corp.
|
Feb 08, 2020 10:20AM
|
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
10
|
Resverlogix Corp.
|
Jan 18, 2016 06:22PM
|
|
Resverlogix Publications, Presentations and Abstracts
|
10
|
Resverlogix Corp.
|
Sep 27, 2017 10:08AM
|
|
Re: The problem...as I see it
|
10
|
Resverlogix Corp.
|
Oct 20, 2020 10:28AM
|
|
Re: New insights from this study -- Questions for scientists.
|
10
|
Resverlogix Corp.
|
Jun 08, 2022 12:06PM
|
|
BETonMACE paper just published
|
10
|
Resverlogix Corp.
|
Mar 27, 2020 01:05PM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
10
|
Resverlogix Corp.
|
Nov 20, 2017 08:16PM
|
|
Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
10
|
Resverlogix Corp.
|
Apr 20, 2021 08:08AM
|
|
Re: PNAS - jbuffet
|
10
|
Resverlogix Corp.
|
Jan 02, 2021 04:27PM
|
|
Big difference between chloroquine and apabetalone
|
10
|
Resverlogix Corp.
|
Mar 30, 2020 09:09AM
|
|
Gilead's GS-5829 flops in mCRPC
|
10
|
Zenith Epigenetics
|
Jul 13, 2022 11:03AM
|
|
8 Minutes at AHA
|
10
|
Resverlogix Corp.
|
Oct 24, 2019 06:57PM
|
|
Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
10
|
Resverlogix Corp.
|
Sep 15, 2020 08:43AM
|
|
New Zenith Clinical Trial Listing: ZEN003694 and Nivolumab w/ or w/o Ipilimumab in Solid Tumors
|
10
|
Zenith Epigenetics
|
Apr 23, 2021 08:04AM
|
|
Re: time to add/3 vs 5 pt. MACE
|
10
|
Resverlogix Corp.
|
Mar 20, 2018 11:23PM
|
|
Re: My general impressions
|
10
|
Resverlogix Corp.
|
Nov 16, 2019 03:49PM
|
|
RVX exposure
|
9
|
Resverlogix Corp.
|
Feb 12, 2016 12:27PM
|
